Related content

Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade

By Syngle Ashit   Vohra Kanchan   Sharma Anjali   Kaur L.  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 763-770

Springer Publishing Company

Access to resources Recommend Favorite

Tumor necrosis factor-alpha (TNF-α)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature

By Cuchacovich Raquel   Hagan Joseph   Khan Tahir   Richert Arthur   Espinoza Luis  

Clinical Rheumatology, Vol. 30, Iss. 1, 2011-01 ,pp. : 133-137

Springer Publishing Company

Access to resources Recommend Favorite

A case of refractory cutaneous polyarteritis nodosa in a patient with hepatitis B carrier status successfully treated with tumor necrosis factor alpha blockade

By Zoshima Takeshi   Matsumura Masami   Suzuki Yasunori   Kakuchi Yasushi   Mizushima Ichiro   Fujii Hiroshi   Yamada Kazunori   Yamagishi Masakazu   Kawano Mitsuhiro  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 1029-1033

Springer Publishing Company

Access to resources Recommend Favorite

Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 32, Iss. 4, 2014-06 ,pp. : 446-454

Karger

Access to resources Recommend Favorite

The Role of Tumor Necrosis Factor- Receptors in Atherosclerosis

By LeBoeuf R.C.   Schreyer S.A.  

Trends in Cardiovascular Medicine, Vol. 8, Iss. 3, 1998-04 ,pp. : 131-138

Elsevier

Access to resources Recommend Favorite